Marko Kataja

430 total citations
9 papers, 341 citations indexed

About

Marko Kataja is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Marko Kataja has authored 9 papers receiving a total of 341 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Ophthalmology, 4 papers in Radiology, Nuclear Medicine and Imaging and 2 papers in Molecular Biology. Recurrent topics in Marko Kataja's work include Retinal Imaging and Analysis (3 papers), Retinal Diseases and Treatments (3 papers) and Retinal Development and Disorders (2 papers). Marko Kataja is often cited by papers focused on Retinal Imaging and Analysis (3 papers), Retinal Diseases and Treatments (3 papers) and Retinal Development and Disorders (2 papers). Marko Kataja collaborates with scholars based in Finland, United States and Germany. Marko Kataja's co-authors include Heikki Arvilommi, P Koivistoinen, Carl-Gustav Gref, Orville A. Levander, Jussi K. Huttunen, Georg Alfthan, J Pikkarainen, Hannu Uusitalo, Hannele Uusitalo‐Järvinen and Peeter Kööbi and has published in prestigious journals such as PLoS ONE, American Journal of Clinical Nutrition and Investigative Ophthalmology & Visual Science.

In The Last Decade

Marko Kataja

8 papers receiving 314 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marko Kataja Finland 6 195 99 74 68 43 9 341
Alina Smalinskienė Lithuania 11 49 0.3× 37 0.4× 81 1.1× 31 0.5× 29 0.7× 34 347
Wendy M.R. Broekmans Netherlands 8 100 0.5× 56 0.6× 131 1.8× 74 1.1× 26 0.6× 8 555
J.R. Lewis United States 4 64 0.3× 88 0.9× 40 0.5× 51 0.8× 29 0.7× 6 176
Dhruba J. Chattopadhyay India 7 110 0.6× 30 0.3× 98 1.3× 5 0.1× 9 0.2× 9 331
Karen A. Riccardi United States 9 63 0.3× 28 0.3× 52 0.7× 100 1.5× 43 1.0× 13 351
Robert Russell United States 6 129 0.7× 28 0.3× 74 1.0× 23 0.3× 6 0.1× 9 324
Rajesh Choudhary India 11 17 0.1× 17 0.2× 115 1.6× 129 1.9× 50 1.2× 29 355
Feda Aljaser Saudi Arabia 10 40 0.2× 31 0.3× 55 0.7× 16 0.2× 8 0.2× 20 268
Elodie Olivier France 11 10 0.1× 50 0.5× 90 1.2× 24 0.4× 12 0.3× 24 323
Dalia A. Elgamal Egypt 11 19 0.1× 14 0.1× 72 1.0× 7 0.1× 13 0.3× 23 311

Countries citing papers authored by Marko Kataja

Since Specialization
Citations

This map shows the geographic impact of Marko Kataja's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marko Kataja with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marko Kataja more than expected).

Fields of papers citing papers by Marko Kataja

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marko Kataja. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marko Kataja. The network helps show where Marko Kataja may publish in the future.

Co-authorship network of co-authors of Marko Kataja

This figure shows the co-authorship network connecting the top 25 collaborators of Marko Kataja. A scholar is included among the top collaborators of Marko Kataja based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marko Kataja. Marko Kataja is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Tuulonen, Anja, Marko Kataja, Vesa Aaltonen, et al.. (2021). A comprehensive model for measuring real-life cost-effectiveness in eyecare: automation in care and evaluation of system (aces-rwm (TM)). STM:n Hallinnonalan avoin julkaisuarkisto (Julkari).
2.
Tuulonen, Anja, Marko Kataja, Vesa Aaltonen, et al.. (2021). A comprehensive model for measuring real‐life cost‐effectiveness in eyecare: automation in care and evaluation of system (aces‐rwm™). Acta Ophthalmologica. 100(3). e833–e840. 9 indexed citations
3.
Nättinen, Janika, Antti Jylhä, Ulla Aapola, et al.. (2018). SWATH-MS Proteomic Analysis of Oxygen-Induced Retinopathy Reveals Novel Potential Therapeutic Targets. Investigative Ophthalmology & Visual Science. 59(8). 3294–3294. 20 indexed citations
4.
Prince, Stuart, Marko Kataja, Kati Kinnunen, et al.. (2016). Lack of R-Ras Leads to Increased Vascular Permeability in Ischemic Retinopathy. Investigative Ophthalmology & Visual Science. 57(11). 4898–4898. 27 indexed citations
5.
Tuulonen, Anja, et al.. (2016). Right services to right patients at right time in right setting in Tays Eye Centre. Acta Ophthalmologica. 94(7). 730–735. 21 indexed citations
6.
Prince, Stuart, Marko Kataja, Kati Kinnunen, et al.. (2015). Increased vascular permeability in R-Ras knockout mice with hypoxia-induced retinopathy and a lack of R-Ras expression in human diabetic retinal neovasculature. Investigative Ophthalmology & Visual Science. 56(7). 4275–4275. 1 indexed citations
7.
Ilmarinen, Tanja, Hanna Hiidenmaa, Peeter Kööbi, et al.. (2015). Ultrathin Polyimide Membrane as Cell Carrier for Subretinal Transplantation of Human Embryonic Stem Cell Derived Retinal Pigment Epithelium. PLoS ONE. 10(11). e0143669–e0143669. 46 indexed citations
8.
Viikari, Jorma, M Välimäki, Jorma Salmi, et al.. (1998). [Growth hormone therapy is useful even for adults].. PubMed. 114(9). 867–77. 1 indexed citations
9.
Levander, Orville A., Georg Alfthan, Heikki Arvilommi, et al.. (1983). Bioavailability of selenium to Finnish men as assessed by platelet glutathione peroxidase activity and other blood parameters. American Journal of Clinical Nutrition. 37(6). 887–897. 216 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026